Abstract:Chagas disease is a severe parasitic illness that is prevalent in Latin America and often goes unaddressed. Early detection and treatment are critical in preventing the progression of the illness and its associated life-threatening complications. In recent years, machine learning algorithms have emerged as powerful tools for disease prediction and diagnosis. In this study, we developed machine learning algorithms to predict the risk of Chagas disease based on five general factors: age, gender, history of living in a mud or wooden house, history of being bitten by a triatomine bug, and family history of Chagas disease. We analyzed data from the Retrovirus Epidemiology Donor Study (REDS) to train five popular machine learning algorithms. The sample comprised 2,006 patients, divided into 75% for training and 25% for testing algorithm performance. We evaluated the model performance using precision, recall, and AUC-ROC metrics. The Adaboost algorithm yielded an AUC-ROC of 0.772, a precision of 0.199, and a recall of 0.612. We simulated the decision boundary using various thresholds and observed that in this dataset a threshold of 0.45 resulted in a 100% recall. This finding suggests that employing such a threshold could potentially save 22.5% of the cost associated with mass testing of Chagas disease. Our findings highlight the potential of applying machine learning to improve the sensitivity and effectiveness of Chagas disease diagnosis and prevention. Furthermore, we emphasize the importance of integrating socio-demographic and environmental factors into neglected disease prediction models to enhance their performance. Chagas disease, a severe parasitic illness prevalent in Latin America, poses significant challenges due to delayed detection and treatment. Machine learning algorithms, advanced computer programs, have emerged as valuable tools for disease prediction and diagnosis. In our study, we utilized these algorithms to forecast Chagas disease risk based on factors such as age, gender, and living conditions. Drawing on data from the Retrovirus Epidemiology Donor Study (REDS), we trained five algorithms, with one showing promising results, achieving an impressive score of 0.772 out of 1. By establishing a specific threshold, we could potentially reduce testing costs while maintaining high detection rates. This research highlights the potential of machine learning in improving Chagas disease diagnosis and prevention by incorporating socio-demographic and environmental factors. Integrating these elements into predictive models has the potential to enhance their effectiveness and sensitivity, thereby improving disease management outcomes and ultimately reducing the burden of Chagas disease in affected regions.

Consumer willingness to pay for a hypothetical Chagas disease vaccine in Brazil: a cross-sectional study and the implications

Willingness to pay for a hypothetical malaria vaccine in Brazil: a cross-sectional study and the implications

Acceptability and willingness to pay for a hypothetical HIV vaccine in Brazil and the implications: a cross-sectional study

Acceptability and willingness to pay for a hypothetical vaccine against SARS CoV-2 by the Brazilian consumer: a cross-sectional study and the implications

Consumer Willingness to Pay for Dengue Vaccine (CYD-TDV, Dengvaxia®) in Brazil; Implications for Future Pricing Considerations

Willingness to Pay for Hypothetical Malaria Vaccines in Rural Burkina Faso

Vaccine Demand and Willingness-to-pay for Arbovirus Vaccines: A Cross-sectional Survey in Rural Guatemala

Willingness-to-pay for COVID-19 vaccine in ten low-middle-income countries in Asia, Africa and South America: A cross-sectional study

The Burden of Chagas Disease in the Contemporary World: The RAISE Study

Willingness to pay for hepatitis B virus vaccine and associated factors among households in Bahir Dar City, northwest Ethiopia: using contingent valuation method

Willingness to Pay for a for a Potential Vaccine Against SARS-CoV-2 / COVID-19 Among Adult Persons

Acceptability and consumers' willingness to pay for comprehensive medication management services in Brazil

Treatments and the Perspectives of Developing a Vaccine for Chagas Disease

Hepatitis A, B, and C in Brazilian Afro-Descendant Communities from Northeast Brazil: A Seroepidemiological Survey

Drastic reduction in the notification of acute cases of Chagas disease in the Northeast region of Brazil. Epidemiological evaluation in the period 2001-2021

Community-based screening of Chagas disease among Latin American migrants in a non-endemic country: an observational study

Mapping the Silent Threat: A Comprehensive Analysis of Chagas Disease Occurrence in Riverside Communities in the Western Amazon

Remembrance and oblivion in vaccine development and vaccination coverage rates in Brazil: addressing vaccinology based on the One Health perspective

Drivers of respiratory health care demand in Acre state, Brazilian Amazon: a cross-sectional study

Access to vaccines in Brazil and the global dynamics of the Health Economic-Industrial Complex

Machine learning for predicting Chagas disease infection in rural areas of Brazil